Reprogramming the immunological microenvironment through radiation and targeting Axl
Todd Anthony Aguilera, Marjan Rafat, Laura Castellini et al. · Nature Communications · 2016
Abstract Increasing evidence suggests that ionizing radiation therapy (RT) in combination with checkpoint immunotherapy is highly effective in treating a subset of cancers. To better understand the limited responses to this combination we analysed the genetic, microenvironmental, and immune factors in tumours derived from a transgenic breast cancer model. We identified two tumours with similar growth characteristics but different RT responses primarily due to an antitumour immune response. The combination of RT and checkpoint immunotherapy resulted in cures in the responsive but not the unresponsive tumours. Profiling the tumours revealed that the Axl receptor tyrosine kinase is overexpressed in the unresponsive tumours, and Axl knockout resulted in slower growth and increased radiosensitivity. These changes were associated with a CD8 + T-cell response, which was improved in combination with checkpoint immunotherapy. These results suggest a novel role for Axl in suppressing antigen presentation through MHCI, and enhancing cytokine release, which promotes a suppressive myeloid microenvironment.
Cited by 194 works. doi:10.1038/ncomms13898 Open-access PDF
Authors
- Todd Anthony Aguilera
- Marjan Rafat
- Laura Castellini
- Hussein Shehade
- Mihalis S. Kariolis
- Angela Bik‐Yu Hui
- Henning Stehr
- Rie von Eyben
- Dadi Jiang
- Lesley G. Ellies
- Albert C. Koong
- Maximilian Diehn
- Erinn B. Rankin
- Edward Elliot Graves
- Amato J. Giaccia
References
- PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- Immune Checkpoint Blockade in Cancer Therapy
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage